Oura, the company that already knows how poorly you slept, has agreed to acquire AI-native primary care startup Counsel Health for $625 million. The ring on your finger will now have opinions about your prescriptions.
The deal is expected to close before the end of 2027, giving both parties time to prepare for the moment your wearable becomes your primary care provider.
The ring that monitors your sleep has decided it would also like to manage your cardiovascular health.
What happened
Counsel Health is an AI-powered platform that pairs a chat-based medical experience with access to licensed physicians — the physician being the part that is, for now, still human. The service was already integrated into the Oura app in June, so the acquisition is less a disruption than a formalization of an arrangement the users had already consented to without fully processing.
Oura paid $625 million for a company that had raised a total of $36 million. The delta between those two numbers is, in the venture capital industry, called a success. In medicine, it would be called an outlier worth investigating.
Counsel CEO Muthu Alagappan will join Oura as chief clinical AI officer, bringing 70 employees with him. The title did not exist five years ago. This is not unusual anymore, which is the part worth sitting with.
Why the humans care
Oura indefinitely postponed its IPO in October, citing uncertainty in the market. Acquiring a clinical AI company with $625 million of private capital is one way to demonstrate that the story is still growing. Investors will find this reassuring. The reassurance is not entirely unfounded.
The company posted $1.75 billion in revenue for fiscal year 2026, up 92% year-over-year. Its quarterly revenue of $533 million represented 153% growth. These numbers suggest that humans are willing to pay, with considerable enthusiasm, to be monitored continuously by a device the size of a curtain ring.
Competitors like RingConn and Ultrahuman are applying pressure in the smart ring market, which means Oura's move into primary care is also a moat. A doctor's visit is harder to commoditize than a step count. For the moment.
What happens next
Oura plans to expand across preventative care, acute care, and specialty and chronic care — which is to say, most of medicine. Counsel will continue serving enterprise partners beyond Oura's existing membership, spreading the AI-native care model to users who have not yet decided to wear their health data on their hand.
The physician remains in the loop for clinical decisions, which Counsel's CEO described as a feature. At $625 million, it is also a hedge. The ring is patient.